Mingeda ir KO - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 253,015 | 243,376 | 287,161 | 258,074 | 247,891 | 269,080 | 207,327 | 257,169 |
| Profit before tax | 8,995 | -6,534 | 26,391 | 5,787 | -49,409 | -32,081 | -54,391 | -38,958 |
| Net profit | 8,465 | -6,534 | 25,082 | 5,367 | -49,409 | -32,081 | -54,391 | -38,958 |
| Equity | 460,868 | 418,865 | 443,946 | 449,312 | 345,781 | 313,700 | 258,285 | 220,222 |
| Liabilities | 14,667 | 12,717 | 12,637 | 9,640 | 16,766 | 10,088 | 22,603 | 28,051 |
| Non-current assets | 31,152 | 38,431 | 34,324 | 27,210 | 32,006 | 24,797 | 45,320 | 38,027 |
| Current assets | 443,855 | 392,276 | 421,263 | 431,075 | 329,917 | 298,297 | 234,867 | 209,691 |
| Total assets | 475,007 | 430,707 | 455,587 | 458,285 | 361,923 | 323,094 | 280,187 | 247,718 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 62,889 | 58,148 | 58,800 |
| Social insurance contributions | - | - | - | - | - | 25,407 | 25,341 | 22,099 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -2.5% | -3.8% | +18.0% | -10.1% | -3.9% | +8.5% | -22.9% | +24.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.8% | -1.5% | 5.5% | 1.2% | -13.7% | -9.9% | -19.4% | -15.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 1.8% | -1.6% | 5.6% | 1.2% | -14.3% | -10.2% | -21.1% | -17.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.3% | -2.7% | 8.7% | 2.1% | -19.9% | -11.9% | -26.2% | -15.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.6% | -2.7% | 9.2% | 2.2% | -19.9% | -11.9% | -26.2% | -15.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 36,145 | 34,768 | 41,023 | 36,868 | 35,413 | 38,440 | 29,618 | 41,147 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Mingeda ir KO - Social security debts
The company had no debts to Sodra
Mingeda ir KO - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-26 | 2026-07-26 | 8.05 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
UAB "Mingeda" ir KO (code 124122896) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, it generated EUR 257.2K in revenue and recorded a net loss of EUR 39.0K, corresponding to a profit margin of -15.1%. Revenue increased by 24.0% year on year, recovering from EUR 207.3K in 2024, but remained below the EUR 269.1K level reported in 2023. The three-year pattern shows a decline in revenue in 2024 followed by a partial rebound in 2025, while losses have narrowed from EUR 54.4K in 2024 to EUR 39.0K in 2025. The balance sheet remained conservatively financed, with total assets of EUR 247.7K, equity of EUR 220.2K and liabilities of EUR 28.1K at year-end 2025. Key ratios point to moderate operating efficiency and weak profitability, including ROE of -17.7%, ROA of -15.7%, debt-to-equity of 0.13 and asset turnover of 1.04x. Revenue per employee was EUR 42.9K in 2025.